Effects of cholesterol depletion, pro‐inflammatory cytokines and the apolipoprotein E isoforms on ABCA7 protein levels in human neural cell lines and brain tissue

• Published in: Alzheimer's & dementia Vol. 19; no. S13
• Main Authors: Wiener, Joel P., Garliyev, Viktor, Desire, Sindy, Pratico, Anna, Serrano, Geidy E, Lyssenko, Nicholas N.
• Format: Journal Article
• Language: English
• Published: 01.12.2023
• ISSN: 1552-5260; 1552-5279
• DOI: 10.1002/alz.079035

Background Strong evidence from diverse sources points to adenosine triphosphate‐binding cassette transporter subfamily A member 7 (ABCA7) as a major risk factor in Alzheimer’s disease (AD). However, the mode of its involvement with the disease and many aspects of its function are understood incompletely. Method Human microglia cells C20 and HMC3 and neuronal cells SK‐N‐SH were either depleted in cholesterol using methyl‐β‐cyclodextrin and/or rosuvastatin or treated with pro‐inflammatory cytokines IL‐1β, IL‐6 or TNFα, and ABCA7 protein levels in these cells were then assessed using a validated monoclonal antibody. ABCA7 levels were also assessed using the antibody in the parietal cortex from 170 donors, who were genotyped for the APOE isoforms. Result Large (∼75%) reductions in intracellular cholesterol and saturating amounts of pro‐inflammatory cytokines IL‐1β and TNFα reduced ABCA7 protein by, respectively, 36.8±9.1% (mean±standard deviation, two‐tailed t test p = 0.0002, n = 4), 53.0±22.6% (p = 0.002, n = 4) and 59.2±8.0% (p = 0.0006, n = 4) in C20 cells and by similar percentages in HMC3 cells. Similarly severe cholesterol depletion had no effect on ABCA7 and IL‐1β and TNFα moderately increased ABCA7 amounts in SK‐N‐SH cells. IL‐6 had no effect on ABCA7 expression in any cell line. IL‐1β and TNFα significantly cross‐induced each other’s secretion in C20 cells. We have previously shown that ABCA7 protein levels drop suddenly during AD pathogenesis between Braak and Braak stages I and II in the human brain. Among the individuals without AD pathology or with Braak stage I pathology, ABCA7 levels were lower in APOE4 carriers without reaching statistical significance (0.74, 0.35‐2.51 vs 1.5, 0.30‐3.16 ABCA7/GAPDH ratios; median, 25%‐75% interval; Mann‐Whitney p = 0.44, n = 68 vs 14); among the individuals with Braak stages II‐V, ABCA7 was also lower in APOE4 carriers (0.21, 0.07‐1.07 vs 0.55, 0.11‐1.35; Mann‐Whitney p = 0.18, n = 53 vs 35). The comparison groups were matched for age, sex and PMI. Conclusion The effect of cholesterol depletion on ABCA7 expression is tissue specific. ABCA7 functions are homeostatic and not compatible with inflammation in microglia. If APOE4 has an effect on ABCA7 levels, it is smaller than the reduction in ABCA7 between Braak stages I and II. These findings improve our understanding of ABCA7 pathophysiology.